James Budge - 23 Feb 2026 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Role
Chief Financial Officer
Signature
/s/ James Budge
Issuer symbol
HNGE
Transactions as of
23 Feb 2026
Net transactions value
-$580,737
Form type
4
Filing time
24 Feb 2026, 16:20:22 UTC
Previous filing
03 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Budge James Chief Financial Officer C/O HINGE HEALTH, INC., 455 MARKET STREET, SUITE 700, SAN FRANCISCO /s/ James Budge 24 Feb 2026 0001338176

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HNGE Class A Common Stock Sale $293,077 -7,566 -1.7% $38.74 427,329 23 Feb 2026 Direct F1, F2
transaction HNGE Class A Common Stock Sale $251,271 -6,297 -1.5% $39.90 421,032 23 Feb 2026 Direct F1, F3
transaction HNGE Class A Common Stock Sale $36,389 -900 -0.21% $40.43 420,132 23 Feb 2026 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
F2 Represents the weighted average sale price. The lowest price at which shares were sold was $38.40 and the highest price at which shares were sold was $39.37. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F3 Represents the weighted average sale price. The lowest price at which shares were sold was $39.40 and the highest price at which shares were sold was $40.39. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
F4 Represents the weighted average sale price. The lowest price at which shares were sold was $40.40 and the highest price at which shares were sold was $40.46. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.